New data of the real clinical practice confirms low incidence of major bleeding when using rivaroxaban in patients with non-valvular atrial fibrillation

New data of the real clinical practice confirms low incidence of major bleeding when using rivaroxaban in patients with non-valvular atrial fibrillation

Show other versions (1)

New data of the real clinical practice confirms low incidence of major bleeding when using rivaroxaban in patients with non-valvular atrial fibrillation

Bibliographic Details
Main Author: article Editorial
Format: Article
Language:English
Published: Stolichnaya Izdatelskaya Kompaniya 2015-11-01
Series:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Online Access:https://www.rpcardio.com/jour/article/view/332

Similar Items

Similar Items